Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (111-120 of 565) with videos related to

Pageof 57
Sort By:
Expert Opinion on Medical Diagnostics|March 19, 2013
Molecular biomarkers for predicting chemotherapy response in lung cancerJia Wei, Baorui Liu, Andres Felipe Cardona, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)Irene Moya-Horno, Santiago Viteri, Niki Karachaliou, et al.
Translational Lung Cancer Research|March 26, 2015
Comprehensive molecular screening: from the RT-PCR to the RNA-seqCarlota Costa, Ana Giménez-Capitán, Niki Karachaliou, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Genetic testing for chemotherapy in non-small cell lung cancerRafael Rosell, Miquel Taron, Vicente Alberola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Current concepts in bronchioloalveolar carcinoma biologyDan J Raz, Biao He, Rafael Rosell, et al.
Cancer Cell|July 12, 2022
Location of EGFR exon 20 insertions mattersAndrés Felipe Cardona, María González-Cao, Oscar Arrieta, et al.
Clinical Lung Cancer|July 28, 2009
Cancer treatments: can we find treasures at the bottom of the sea?Mariano Provencio, Antonio Sánchez, Joan Gasent, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
DNA repair and cisplatin resistance in non-small-cell lung cancerRafael Rosell, Reginald V N Lord, Miquel Taron, et al.
Clinical Lung Cancer|April 28, 2006
Bronchioloalveolar carcinoma: a reviewDan J Raz, Biao He, Rafael Rosell, et al.
Expert Review of Molecular Diagnostics|April 11, 2013
Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapiesRosa Nadal, José Antonio Lorente, Rafael Rosell, et al.
Pageof 57

Showing results (111-120 of 565) with videos related to

Sort By:
Pageof 57
Expert Opinion on Medical Diagnostics|March 19, 2013
Molecular biomarkers for predicting chemotherapy response in lung cancerJia Wei, Baorui Liu, Andres Felipe Cardona, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)Irene Moya-Horno, Santiago Viteri, Niki Karachaliou, et al.
Translational Lung Cancer Research|March 26, 2015
Comprehensive molecular screening: from the RT-PCR to the RNA-seqCarlota Costa, Ana Giménez-Capitán, Niki Karachaliou, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Genetic testing for chemotherapy in non-small cell lung cancerRafael Rosell, Miquel Taron, Vicente Alberola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Current concepts in bronchioloalveolar carcinoma biologyDan J Raz, Biao He, Rafael Rosell, et al.
Cancer Cell|July 12, 2022
Location of EGFR exon 20 insertions mattersAndrés Felipe Cardona, María González-Cao, Oscar Arrieta, et al.
Clinical Lung Cancer|July 28, 2009
Cancer treatments: can we find treasures at the bottom of the sea?Mariano Provencio, Antonio Sánchez, Joan Gasent, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
DNA repair and cisplatin resistance in non-small-cell lung cancerRafael Rosell, Reginald V N Lord, Miquel Taron, et al.
Clinical Lung Cancer|April 28, 2006
Bronchioloalveolar carcinoma: a reviewDan J Raz, Biao He, Rafael Rosell, et al.
Expert Review of Molecular Diagnostics|April 11, 2013
Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapiesRosa Nadal, José Antonio Lorente, Rafael Rosell, et al.
Pageof 57